Home > Research > Publications & Outputs > On plasma fractionation treatment and its impli...


Text available via DOI:

View graph of relations

On plasma fractionation treatment and its implications in cells

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>30/12/2022
<mark>Journal</mark>IEEE Transactions on Radiation and Plasma Medical Sciences
Issue number1
Pages (from-to)96-102
Publication StatusPublished
Early online date26/05/22
<mark>Original language</mark>English


Here we present a novel plasma treatment regime– plasma fractionation, analogous to the concept of dose fractionation in radiotherapy, which could see application in plasma-based cancer treatment. In plasma fractionation, a single acute dose of plasma is divided into multiple small dosages (fractionated dosages) and administered to the cells in vitro at 24-hour intervals. We utilised a helium plasma jet and studied the effects of plasma fractionation in an immortalised keratinocyte line (HaCaT) and a squamous cell carcinoma line (A431). The effects were assessed over three cell seeding densities – 8000, 3500
and 1000 cells/well. Our results show that, at all seeding densities, plasma fractionation produced lower levels of cell death in both cell types compared to the same dose administered as a single plasma treatment. This highlights the potential of plasma fractionation as a potentially safer method to conduct plasma treatments in future. We also show that A431 cells were more sensitive to a single acute plasma treatment than HaCaT cells, at cell densities that are sub-confluent (1000 cells/well). A similar difference in sensitivity between HaCaT cells and A431 cells was not observed on exogenous treatment with hydrogen peroxide, pointing to the importance of other shorter-lived plasma components.